Types of previous assessment | Quality data | Non-clinical data | Clinical data |
---|
The investigational medicinal product is authorised or has a marketing authorisation in an ICH country and is used in the clinical trial: | | | |
—within the conditions of the SmPC | SmPC |
—outside the conditions of the SmPC | SmPC | If appropriate | If appropriate |
—after modification (for example blinding) | P+A | SmPC | SmPC |
Another pharmaceutical form or strength of the investigational medicinal product is authorised or has a marketing authorisation in an ICH country and the investigational medicinal product is supplied by the marketing authorisation holder | SmPC+P+A | Yes | Yes |
The investigational medicinal product is not authorised and has no marketing authorisation in an ICH country but the active substance is contained in an authorised medicinal product, and | | | |
—is supplied by the same manufacturer | SmPC+P+A | Yes | Yes |
—is supplied by another manufacturer | SmPC+S+P+A | Yes | Yes |
The investigational medicinal product was subject to a previous clinical trial application and authorised in the Member State concerned and has not been modified, and | | | |
—no new data are available since last amendment to the clinical trial application, | Reference to previous submission |
—new data are available since last amendment to the clinical trial application, | New data | New data | New data |
—is used under different conditions | If appropriate | If appropriate | If appropriate |